Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Find effective wealth accumulation strategies designed specifically for young professionals. Start building your financial future today.
17,961 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Buying nebius group stock represents a high-conviction AI infrastructure play. This guide breaks down the business, m...
Travel trends shifting—here’s it’s changing where guests stay, how long they visit, and what hosts can charge. This g...
A shift is sweeping real estate finance: lenders are resetting terms, buyers are adjusting plans, and landlords are l...
Coinbase is expanding the Ethereum ecosystem with Base, an Ethereum Layer-2 network designed for speed, low fees, an...
Rumors around chip supply and product timelines can move markets quickly. This guide shows how AMD typically responds...
Barings BDC (BBDC) fans the flames of income investing with a steady cash-flow model. As barings (bbdc) 2025 earnings...
The CEO of a $1B AI unicorn pushes back on doom-laden talk about job loss, arguing that funding cycles and strategic ...
A court decision upends White House tariff policy, leaving $175 billion in IEEPA duties in limbo. The Treasury secret...
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
A new AI-powered marketing platform is offering shares at $0.85 in a Reg A+ round, drawing comparisons to early Nvidi...
This article breaks down DigitalOcean's hypothetical 2025 earnings transcript to help investors gauge growth quality,...